Apr 13, 2015 · Few data exist about the long-term durability of the immune response after antipneumococcal vaccination. In older adults, after being given one ...
Apr 13, 2015 · Our goal was to assess the maintenance of the immune response to pneumococcal vaccines in patients vaccinated 10 years ago according to current guidelines.
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Cordonnier, C; Labopin ...
Our findings suggest that PCV given at an early stage of CLL could result in antibody persistence lasting at least five years. The effectiveness and schedule of ...
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Estás aquí: Inicio ...
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. 请求原文 语义增强. 摘要 ...
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Bone Marrow Transplant ...
People also ask
What is the efficacy of the pneumococcal vaccine?
What is the difference between pneumococcal polysaccharide vaccine and pneumococcal conjugate vaccine?
Is the pneumococcal vaccine live or non live?
What is the 14 valent pneumococcal conjugate vaccine?
Jun 4, 2024 · Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial.
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Bone Marrow Transplant ...
Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial. Article 13 April 2015 ...